ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #3,351Top JournalHybrid

FASEB Journal

Abbreviation (ISO):FASEB J
•
Identifier (ISSN):0892-6638(Print)/1530-6860(Online)
•
Publisher:FASEB
Clarivate IF (2026)
4.3↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for FASEB Journal

WoS Q2
24685.5920185.3920194.9720205.1920215.8320224.820234.420244.220254.32026
Annual Impact Factor Metric
Current (2026):4.3
Scopus SJR & RankScopus Q1
1.255
#3,351

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
320

320 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
774articles/year
42.02% Gold OA•95.58% Original Research

Aims & Scope

The FASEB Journal publishes international, transdisciplinary research covering all fields of biology at every level of organization: atomic, molecular, cell, tissue, organ, organismic and population. While the journal strives to include research that cuts across the biological sciences, it also considers submissions that lie within one field, but may have implications for other fields as well. The journal seeks to publish basic and translational research, but also welcomes reports of pre-clinical and early clinical research. In addition to research, review, and hypothesis submissions, The FASEB Journal also seeks perspectives, commentaries, book reviews, and similar content related to the life sciences in its Up Front section.

Topics Covered (Recognized by AI)
BiologyMedicineChemistryInternal MedicineBiochemistryGeneticsEndocrinologyCell BiologyOrganic ChemistryPhysicsPsychologyPathologyReceptors & Pharmacology

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q2
Rank119/328
IndexSCIE
JCRSCIE2026

BIOLOGY

Q1
Rank19/106
IndexSCIE
JCRSCIE2026

CELL BIOLOGY

Q2
Rank94/207
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q2
Rank98/328
IndexSCIE
JCISCIE2026

BIOLOGY

Q1
Rank23/106
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q2
Rank73/207
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.3
Articles / Year927
Total Citations378
2025
IF4.2
Articles / Year1,132
Total Citations3,558
2024
IF4.4
Articles / Year802
Total Citations5,801
2023
IF4.8
Articles / Year658
Total Citations7,567
2022
IF5.834
Articles / Year5,877
Total Citations12,406

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,351Scopus Q1SCImago Profile
Scopus Coverage:1987-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.255

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.99

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,519 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,200
3-Year Documents1,953
Citable Documents1,932

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate44.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ1
BiotechnologyQ1
GeneticsQ1
Medicine (miscellaneous)Q1
Molecular BiologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Biology
Minor Category (Specific Field):
2区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

FASEB Journal (abbr: FASEB J, ISSN: 0892-6638) is a peer-reviewed international scholarly journal in the field of Biology, published by FASEB in United States since 1987. The periodical holds a Journal Impact Factor (JIF) of 4.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.255 (Q1), an H-index of 320.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 774 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,519 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
FASEB
Publication Language
English
Frequency
Monthly
Founding Year
1987
Indexing & Databases
SCIEScopusPubMed
Editorial Address
FEDERATION AMER SOC EXP BIOL, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3998

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6113f2ce-2de8-4c7c-a7e3-58cf8554bae2
Database Updated: 2026-09-28